Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms 81c6, a murine igg2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131), Iodine I-131 monoclonal antibody 81c6, Iodine i 131 moab 81c6 + [4] |
Target |
Mechanism tenascin inhibitors(Tenascin inhibitors), Ionising radiation emitters |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 3 | - | 01 Jun 2008 | |
Glioblastoma | Phase 3 | US | - | |
Glioblastoma | Phase 3 | - | - |
Phase 2 | 42 | (waeisxgosf) = gjsusmuhtj izxigjhqfu (sqvivbmkys ) | Positive | 15 Jul 2004 | |||
- |